Testing effectiveness (Phase 2)WithdrawnNCT01636128
What this trial is testing
Urinary Biomarker Study With Sulindac and Difluoromethylornithine
Who this might be right for
Focus of Study: Drug Response Biomarkers, Chemoprevention, Neoplasms
Cancer Prevention Pharmaceuticals, Inc.